Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats

European Journal of Pharmacology

Volumn 616, Issue 1-3, 2009, Pages 175-182

  Cobos Puc, Luis E ^a   Villalón, Carlos M ^a   Ramírez Rosas, Martha B ^a   Sánchez López, Araceli ^a   Lozano Cuenca, Jair ^a   Gómez Díaz, Benjamín ^a   MaassenVanDenBrink, Antoinette ^b   Centurión, David ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

2 adrenoceptor; AGN192403; BU224; Imidazoline receptors; Moxonidine; Sympatho inhibition

Indexed keywords

2 (2 IMIDAZOLIN 2 YL)QUINOLINE; 2 ENDO AMINO 3 EXOISOPROPYLBICYCLO[2.2.1]HEPTANE HYDROCHLORIDE; AGMATINE; AGN 192403; ALPHA 2 ADRENERGIC RECEPTOR; AZEPEXOLE; IMIDAZOLINE I1 RECEPTOR; MOXONIDINE; NORADRENALIN; RAUWOLSCINE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ARTICLE; BOLUS INJECTION; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SPINAL ANIMAL; SYMPATHETIC FUNCTION; SYMPATHETIC INNERVATION; TACHYCARDIA; WISTAR RAT;

AGMATINE; ANIMALS; AZEPINES; BICYCLO COMPOUNDS; BRAIN; ELECTRIC STIMULATION; HEART RATE; HEPTANES; IMIDAZOLES; INFUSIONS, INTRAVENOUS; MALE; NOREPINEPHRINE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; SODIUM CHLORIDE; SUBSTRATE SPECIFICITY; SYMPATHETIC NERVOUS SYSTEM; TACHYCARDIA; TIME FACTORS; YOHIMBINE;

EID: 67849121289     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.06.003     Document Type: Article

References (31)

1. Armah B.I. Unique presynaptic alpha 2-receptor selectivity and specificity of the antihypertensive agent moxonidine. Arzneimittelforschung 38 (1988) 1435-1442
2. Atlas D. Identifying clonidine-displacing substance. Science 266 (1994) 462-464
3. Atlas D. Molecular and physiological properties of clonidine-displacing substance. Ann. N.Y. Acad. Sci. 763 (1995) 314-324
4. Boehm S., and Kubista H. Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol. Rev. 54 (2002) 43-99
5. 2C-adrenoceptors mediate the inhibition of cardioaccelerator sympathetic outflow in pithed rats. Eur. J. Pharmacol. 554 (2007) 205-211
6. Cobos-Puc L.E., Villalón C.M., Sánchez-López A., Ramírez-Rosas M.B., Lozano-Cuenca J., Pertz H.H., Gornemann T., and Centurión D. Pharmacological characterization of ergotamine-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats. Naunyn Schmiedebergs Arch. Pharmacol. 379 (2009) 137-148
7. 1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease. J. Hypertens. Suppl. 15 (1997) S9-S23
8. 2 imidazoline receptors in human striatum. Neurochem. Int. 30 (1997) 25-29
9. Gillespie J.S., MacLaren A., and Pollock D. A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat. Br. J. Pharmacol. 40 (1970) 257-267
10. Guimarães S., and Moura D. Vascular adrenoceptors: an update. Pharmacol. Rev. 53 (2001) 319-356
11. Hammer R., Kobinger W., and Pichler L. Binding of an imidazolidine (clonidine), an oxazoloazepin (B-HT 933) and a thiazoloazepin (B-HT 920) to rat brain α-adrenoceptors and relation to cardiovascular effects. Eur. J. Pharmacol. 62 (1980) 277-285
12. 2-adrenergic receptors regulate sympathetic neurotransmission. Nature 402 (1999) 181-184
13. 2-adrenoceptors. Prog. Drug Res. 47 (1996) 81-130
14. Kleinman L.I., and Radford E.P.J. Ventilation standards for small mammals. J. Appl. Physiol. 19 (1964) 360-362
15. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., and Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263 (1994) 966-969
16. 2-imidazoline binding sites. Naunyn Schmiedebergs Arch. Pharmacol. 351 (1995) 507-516
17. Molderings G.J., Hentrich F., and Göthert M. Pharmacological characterization of the imidazoline receptor which mediates inhibition of noradrenaline release in the rabbit pulmonary artery. Naunyn Schmiedebergs Arch. Pharmacol. 344 (1991) 630-638
18. 3H]idazoxan binding sites in human cardiovascular tissues. Br. J. Pharmacol. 122 (1997) 43-50
19. Monroy-Ordoñez E.B., Villalón C.M., Cobos-Puc L.E., Márquez-Conde J.A., Sánchez-López A., and Centurión D. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats. Auton. Neurosci. 143 (2008) 40-45
20. Munk S.A., Lai R.K., Burke J.E., Arasasingham P.N., Kharlamb A.B., Manlapaz C.A., Padillo E.U., Wijono M.K., Hasson D.W., Wheeler L.A., and Garst M.E. Synthesis and pharmacologic evaluation of 2-endo-amino-3-exo-isopropylbicyclo[2.2.1]heptane: a potent imidazoline1 receptor specific agent. J. Med. Chem. 39 (1996) 1193-1195
21. 2-adrenoceptors. J. Pharmacol. Exp. Ther. 304 (2003) 1063-1071
22. 1 receptors. Neurosci. Plan. Meet. 296 (2007) 10
23. 2-adrenoceptors. J. Pharmacol. Exp. Ther. 303 (2002) 1163-1170
24. 2-adrenoceptor-dependent synergistic sympathoinhibitory action at imidazoline-1 receptors. Ann. N.Y. Acad. Sci. 1009 (2003) 265-269
25. Shipley R.E., and Tilden J.H. A pithed rat preparation suitable for assaying pressor substances. Proc. Soc. Exp. Biol. Med. 64 (1947) 453-455
26. Steel R.G.D., and Torrie J.H. Principles and Procedures of Statistics: A Biomedical Approach. Second edition (1980), McGraw-Hill Kogakusha, Tokyo
27. Szabo B. Imidazoline antihypertensive drugs: a critical review on their mechanism of action. Pharmacol. Ther. 93 (2002) 1-35
28. Szabo B., Bock C., Nordheim U., and Niederhoffer N. Mechanism of the sympathoinhibition produced by the clonidine-like drugs rilmenidine and moxonidine. Ann. N.Y. Acad. Sci. 881 (1999) 253-264
29. 2-adrenoceptor stimulation. Naunyn Schmiedebergs Arch. Pharmacol. 313 (1980) 17-20
30. Villalón C.M., and Centurión D. Cardiovascular responses produced by 5-hydroxytryptamine: a pharmacological update on the receptors/mechanisms involved and therapeutic implications. Naunyn Schmiedebergs Arch. Pharmacol. 376 (2007) 45-63
31. Villalón C.M., Centurión D., del Mar F.M., Morán A., and Sánchez-López A. 5-Hydroxytryptamine inhibits the tachycardia induced by selective preganglionic sympathetic stimulation in pithed rats. Life Sci. 64 (1999) 1839-1847